I am pleased to announce the launch of Bioeconomy Capital. Our investments so far are:

• Riffyn, which is building software that provides experimental process design and analytics software to improve reproducibility and tech transfer in life science and materials R&D;
• Synthace, which is increasing the reliability, quality, and scale of biological science;
• RoosterBio, which is is creating exponential advances in stem cell manufacturing to provide raw materials for cell-based therapies, biofabrication, and cellular ink for 3D BioPrinting.